Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “P2Y12 Inhibitor”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Testing effectiveness (Phase 2)Looking for participantsNCT05926271
What this trial is testing

POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy

Who this might be right for
Acute Coronary SyndromeCYP2C19 Polymorphism
St. Antonius Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT00546260
What this trial is testing

Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI

Who this might be right for
Myocardial Infarction
Portola Pharmaceuticals 70
Post-approval studies (Phase 4)Study completedNCT01950416
What this trial is testing

Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Post Fibrinolysis

Who this might be right for
ST Elevation Myocardial InfarctionFibrinolysisP2Y12 Inhibitor
University of Patras 56
Not applicableStudy completedNCT04492423
What this trial is testing

VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study

Who this might be right for
Coronary DiseasePlatelet Aggregation
Accriva Diagnostics 100
Post-approval studies (Phase 4)Looking for participantsNCT05681702
What this trial is testing

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

Who this might be right for
Coronary Artery Disease
University of Florida 90
Post-approval studies (Phase 4)Study completedNCT02018055
What this trial is testing

TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI

Who this might be right for
Acute Myocardial Infarction
The Catholic University of Korea 2,590
Post-approval studies (Phase 4)Looking for participantsNCT05491200
What this trial is testing

Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

Who this might be right for
ST Elevated Myocardial InfarctionDual Antiplatelet Therapy
Research Maatschap Cardiologen Rotterdam Zuid 1,656
Post-approval studies (Phase 4)Temporarily pausedNCT03729401
What this trial is testing

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND

Who this might be right for
Coronary Artery DiseaseMyocardial Infarction
Ottawa Heart Institute Research Corporation 390
Not applicableLooking for participantsNCT06535568
What this trial is testing

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Who this might be right for
Coronary DiseaseHeart DiseasesCardiovascular Diseases+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS 576
Not applicableStudy completedNCT05581238
What this trial is testing

Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.

Who this might be right for
Platelet AggregationBlood Transfusion
Medisch Spectrum Twente 6,428
Not applicableLooking for participantsNCT04923191
What this trial is testing

The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent

Who this might be right for
Coronary Artery Disease
National University of Ireland, Galway, Ireland 2,540
Early research (Phase 1)Study completedNCT03126695
What this trial is testing

Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Who this might be right for
Sickle Cell Disease
AstraZeneca 44
Not applicableNot Yet RecruitingNCT05650411
What this trial is testing

Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)

Who this might be right for
Left Main Coronary Artery Stenosis
IGLESIAS Juan Fernando 828
Not applicableStudy completedNCT05858918
What this trial is testing

Ticagrelor vs. Clopidogrel in Post PCI Patients

Who this might be right for
Stable Chronic Angina
Shiraz University of Medical Sciences 476
Large-scale testing (Phase 3)Ended earlyNCT02404363
What this trial is testing

Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy

Who this might be right for
Locally Advanced Pancreatic CancerAdenocarcinoma, PancreasMetastatic Pancreatic Cancer
Assistance Publique - Hôpitaux de Paris 39
Post-approval studies (Phase 4)Not Yet RecruitingNCT06613191
What this trial is testing

Colonoscopy and Antiplatelet Therapy Trial

Who this might be right for
Coronary Arterial Disease (CAD)Peripheral Vascular Disease
Ochsner Health System 100
Post-approval studies (Phase 4)Looking for participantsNCT06283888
What this trial is testing

CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention

Who this might be right for
ACS - Acute Coronary SyndromeCYP2C19 Polymorphism
Zunyi Medical College 1,200
Testing effectiveness (Phase 2)Study completedNCT00751231
What this trial is testing

Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI

Who this might be right for
Percutaneous Coronary Intervention
Portola Pharmaceuticals 652
Post-approval studies (Phase 4)Active Not RecruitingNCT05767723
What this trial is testing

Platelet Sub-study of the Neomindset Trial

Who this might be right for
Acute Coronary Syndrome
Hospital Israelita Albert Einstein 48
Post-approval studies (Phase 4)Not Yet RecruitingNCT07203846
What this trial is testing

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

Who this might be right for
ACS - Acute Coronary SyndromeTicagrelorMicrobiota+10 more
Collegium Medicum w Bydgoszczy 50
Load More Results